Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ivan Diamond

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
The Journal of Biological Chemistry|February 6, 2004
State-specific monoclonal antibodies identify an intermediate state in epsilon protein kinase C activationMiriam C Souroujon, Lina Yao, Haibin Chen, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|February 21, 2007
Characterization of the potency, selectivity, and pharmacokinetic profile for six adenosine A2A receptor antagonistsMing Yang, Daniel Soohoo, Sandriyana Soelaiman, et al.
Behavioural Pharmacology|March 8, 2014
GS 455534 selectively suppresses binge eating of palatable food and attenuates dopamine release in the accumbens of sugar-bingeing ratsMiriam E Bocarsly, Bartley G Hoebel, Daniel Paredes, et al.
Nature Medicine|August 24, 2010
Inhibition of aldehyde dehydrogenase-2 suppresses cocaine seeking by generating THP, a cocaine use-dependent inhibitor of dopamine synthesisLina Yao, Peidong Fan, Maria Arolfo, et al.
Cureus|June 22, 2026
Research Training of Future Leaders in Radiology: A Pilot International Outreach Educational ProgramAndrea S Doria, Jennifer R McKinney, Aleena Malik, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|January 20, 2025
Preliminary effects of oral ANS-6637, an ALDH2 inhibitor, on cue-induced craving, safety and alcohol consumption among adults with alcohol use disorder: a proof-of-concept, randomized, human laboratory trialStephanie S O'Malley, Robert Miranda, Sarah W Book, et al.
Alcoholism, Clinical and Experimental Research|August 14, 2009
Suppression of heavy drinking and alcohol seeking by a selective ALDH-2 inhibitorMaria P Arolfo, David H Overstreet, Lina Yao, et al.
Nature Reviews. Gastroenterology & Hepatology|June 7, 2024
Designing clinical trials to address alcohol use and alcohol-associated liver disease: an expert panel Consensus StatementBrian P Lee, Katie Witkiewitz, Jessica Mellinger, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
The Journal of Biological Chemistry|February 6, 2004
State-specific monoclonal antibodies identify an intermediate state in epsilon protein kinase C activationMiriam C Souroujon, Lina Yao, Haibin Chen, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|February 21, 2007
Characterization of the potency, selectivity, and pharmacokinetic profile for six adenosine A2A receptor antagonistsMing Yang, Daniel Soohoo, Sandriyana Soelaiman, et al.
Behavioural Pharmacology|March 8, 2014
GS 455534 selectively suppresses binge eating of palatable food and attenuates dopamine release in the accumbens of sugar-bingeing ratsMiriam E Bocarsly, Bartley G Hoebel, Daniel Paredes, et al.
Nature Medicine|August 24, 2010
Inhibition of aldehyde dehydrogenase-2 suppresses cocaine seeking by generating THP, a cocaine use-dependent inhibitor of dopamine synthesisLina Yao, Peidong Fan, Maria Arolfo, et al.
Cureus|June 22, 2026
Research Training of Future Leaders in Radiology: A Pilot International Outreach Educational ProgramAndrea S Doria, Jennifer R McKinney, Aleena Malik, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|January 20, 2025
Preliminary effects of oral ANS-6637, an ALDH2 inhibitor, on cue-induced craving, safety and alcohol consumption among adults with alcohol use disorder: a proof-of-concept, randomized, human laboratory trialStephanie S O'Malley, Robert Miranda, Sarah W Book, et al.
Alcoholism, Clinical and Experimental Research|August 14, 2009
Suppression of heavy drinking and alcohol seeking by a selective ALDH-2 inhibitorMaria P Arolfo, David H Overstreet, Lina Yao, et al.
Nature Reviews. Gastroenterology & Hepatology|June 7, 2024
Designing clinical trials to address alcohol use and alcohol-associated liver disease: an expert panel Consensus StatementBrian P Lee, Katie Witkiewitz, Jessica Mellinger, et al.
Pageof 4